Device Trial Radar · NCT06700512
Standard Post Market Clinical Follow-up (PMCF) Study WSA @ HZO
Last checked: Nov 19, 2026Latest source record: Aug 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Jun 14, 2024
Primary completion
Aug 13, 2024
Study completion Aug 26, 2024
Sponsor
- Lead sponsor
- WSAUD A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 22, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to follow-up on a released low-risk device as part of standard PMCF activities
Conditions
- Hearing Loss, Sensorineural
Interventions
Hearing Aid Signia Pure C&G 7IXDevice
Receiver in Canal (RIC) hearing aid, M Receiver
Own Hearing AidDevice
subjects' own hearing aids, any brand, any model
Primary outcomes
What the sponsor says the trial is designed to measure.
- Oldenburg Sentence TestTime frame: Estimated Time Frame 2 weeks (Test conducted at second lab session).
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hörzentrum Oldenburg gGmbH
Oldenburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.